ConductScience.org, home

Paper2441995

Evaluation of the efficacy and tolerance of the antiarrhythmic agent transcainide (R 54718).

Stroobandt R and 3 others. Eur J Clin Pharmacol, 1987. Cited by 2 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Evaluation of the efficacy and tolerance of the antiarrhythmic agent transcainide (R 54718). Papers, record 2441995. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2441995

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluation of the efficacy and tolerance of the antiarrhythmic agent transcainide (R 54718).
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1987
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.08
iCite
Revised in PubMed
2019-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stroobandt RR
2Bennett PBP B
3Hondeghem LML M
4Kesteloot HH

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Arrhythmia AgentsMajor topic
Arrhythmias, CardiacMajor topic
LidocaineMajor topic
Administration, Oral
Adult
Aged
Atrial Flutter
Cardiac Complexes, Premature
Electrocardiography
Exercise Test
Female
Humans
Injections, Intravenous
Male
Middle Aged
Tachycardia
Tachycardia, Atrioventricular Nodal Reentry

Source PubMed

Download CSV of topics

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16397356Efficacy and tolerance of intravenous flecainide in patients with chronic high frequency ventricular arrhythmias.Eur Heart J1984https://conductscience.org/library/papers/6397356PubMed
26176355Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.Circulation1982https://conductscience.org/library/papers/6176355PubMed
33879420Efficacy and tolerance of intravenous lorcainide in patients with normal and impaired intraventricular conduction.Acta Cardiol1985https://conductscience.org/library/papers/3879420PubMed
46421879Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervals.J Clin Invest1984https://conductscience.org/library/papers/6421879PubMed
56984586Reproducibility of exercise-induced ventricular premature beats.Acta Cardiol1982https://conductscience.org/library/papers/6984586PubMed
693050Clinical experience of encainide (MJ 9067): a new anti-arrhythmic drug.Eur J Clin Pharmacol1979https://conductscience.org/library/papers/93050PubMed
72442531Sodium channel block by a potent, new antiarrhythmic agent, transcainide, in guinea pig ventricular myocytes.J Cardiovasc Pharmacol1987https://conductscience.org/library/papers/2442531PubMed
84121909Aprindine (AC 1802), a new anti-arrhythmic drug.Acta Cardiol1973https://conductscience.org/library/papers/4121909PubMed
92870805Clinical pharmacology of old and new antiarrhythmic drugs.Cardiovasc Clin1985https://conductscience.org/library/papers/2870805PubMed
103569425Cardiac electrophysiologic effects of R 54718.Eur J Pharmacol1987https://conductscience.org/library/papers/3569425PubMed
116475789Differential effects of O-demethyl encainide on induced and spontaneous arrhythmias in the conscious dog.Am J Cardiol1984https://conductscience.org/library/papers/6475789PubMed
12603318Clinical experience with lorcainide (R 15 889), a new anti-arrhythmic drug.Arch Int Pharmacodyn Ther1977https://conductscience.org/library/papers/603318PubMed
136203481Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs.Annu Rev Pharmacol Toxicol1984https://conductscience.org/library/papers/6203481PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2441995

GET https://conductscience.org/api/papers/v1/2441995/authors